Pharma & Biotech

The competitive landscape for obesity treatments is heating up, fueling speculation about potential industry consolidation. At the center of this...

Shares of biotechnology firm Skye Bioscience are experiencing significant turmoil. The company is now confronting a class action lawsuit filed...

Shares of Gilead Sciences are consolidating near the $120 level following significant clinical and financial developments. The company announced that...

While Clover Health Investments, Corp. (NASDAQ: CLOV) shares continue to face downward pressure, a newly scheduled event has given market...

Shares of Viking Therapeutics are currently trading within a narrow band between $35 and $36, continuing a period of consolidation...

The investment case for pharmaceutical giant Novo Nordisk is encountering significant pressure. A combination of revised analyst outlooks, emerging legal...

Shares of clinical-stage biopharmaceutical company Ocugen saw elevated trading activity on Monday, with volume running 72% above the average. This...

A significant disconnect has emerged between Healwell AI Inc.'s operational results and its stock market valuation. Despite posting record-breaking quarterly...

Ocugen's stock closed at $1.38 on Friday, marking a single-day gain of 5.34%. This advance represents the third consecutive trading...

The biotechnology firm Ocugen enters the new trading week with positive momentum. Following a multi-day advance, investors are assessing whether...